首页> 外文期刊>Cerebrovascular diseases >Statins Use and Outcome of Acute Ischemic Stroke Patients after Systemic Thrombolysis
【24h】

Statins Use and Outcome of Acute Ischemic Stroke Patients after Systemic Thrombolysis

机译:系统性溶栓后急性缺血性卒中患者的他汀类药物使用和结果

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Aim: The aim of this was to study the effects of statins and their intensity on symptomatic intracranial hemorrhage (sICH) and outcome after IV thrombolysis (IVT) for acute ischemic stroke (AIS). Methods: We retrospectively reviewed the medical records and cerebrovascular images of all the patients treated with IVT for AIS in our center in a 10-year period. Patients were further characterized as any statin users versus non-users on admission to the emergency department. Statins were categorized in high intensity or low intensity statin based on its propensity to reduce lower low-density cholesterol by >= 45% or <45%, respectively. Safety and discharge modified Rankin Score were compared between statin users versus non-users and also between high-intensity versus low-intensity groups. Results: A total of 834 patients received IVT for AIS in our center during a 10-year period. Multivariate models were adjusted for age, NIH Stroke Scale at admission, INR, and history of DM and atrial fibrillation. There was no association between odds of sICH and any statin use (OR = 0.52 [0.26-1.03], p = 0.06). In multivariate model, any statin use was not associated with odds of poor outcome (Table 4: OR = 1.01 [0.79-1.55], p = 0.57). There was no significant association between odds of sICH among patients on high-intensity statin compared to low intensity statin (multivariate model OR = 0.39 [0.11-1.40], p = 0.15). There was 47% reduced odds of poor outcome among patients on high-intensity statin as compared to low-intensity statin (OR = 0.53[0.32-0.88] p = 0.01). However, this significant association was lost in the multivariate model (OR = 0.60 [0.35-1.05], p = 0.07). Conclusion: Our study does not show any significant association between risk of sICH and poor outcome after IVT for patients on prior statin therapy. We also did not find significant association between the risk of sICH and poor outcome after IVT and the intensity of the stain used.
机译:目的:研究他汀类药物及其浓度对急性缺血性卒中(AIS)症状性颅内出血(sICH)和静脉溶栓(IVT)后预后的影响。方法:回顾性分析10年来我中心所有接受IVT治疗的AIS患者的病历和脑血管图像。患者在急诊科入院时进一步被描述为任何他汀类药物使用者和非使用者。根据他汀类药物降低低密度胆固醇的倾向性,分别将他汀类药物分为高强度他汀类药物和低强度他汀类药物。比较他汀类药物使用者与非使用者之间以及高强度组与低强度组之间的安全性和出院修正Rankin评分。结果:在10年的时间里,我们中心共有834名患者接受了AIS IVT。多变量模型根据年龄、入院时NIH卒中评分、INR、糖尿病和心房颤动病史进行调整。sICH的几率与任何他汀类药物的使用之间没有关联(OR=0.52[0.26-1.03],p=0.06)。在多变量模型中,任何他汀类药物的使用都与不良预后的几率无关(表4:OR=1.01[0.79-1.55],p=0.57)。与低强度他汀类药物相比,服用高强度他汀类药物的患者发生sICH的几率没有显著相关性(多变量模型OR=0.39[0.11-1.40],p=0.15)。与低强度他汀类药物相比,高强度他汀类药物治疗患者预后不良的几率降低了47%(OR=0.53[0.32-0.88]p=0.01)。然而,在多变量模型中,这种显著的相关性消失了(OR=0.60[0.35-1.05],p=0.07)。结论:我们的研究没有显示在接受他汀类药物治疗的患者IVT后发生sICH的风险与不良预后之间存在显著相关性。我们也没有发现sICH的风险与IVT后不良结局以及使用的染色强度之间存在显著关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号